Login

Arun Jain, Chairman and CEO of Polaris Financial Technology Ltd., shares his views on ... 00:10:00

Share On Facebook Share On Twitter

Arun Jain, Chairman and CEO of Polaris Financial Technology Ltd

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
"Empowering Creativity: Oscar Höglund's Vision for the Music Industry"
00:10:00
help achieve our mission of Transforming the Moving World|Cyrus Sigari, Managing Partner,UP Partners
00:10:00
Phunware CEO Alan Knitowski reveals the details of the company's 2Q performance, showcasing a remarkable 282% year-over-year surge in net revenue.|Mike Snavely is Chief Executive Officer & Director of Phunware
00:10:00
Archilc's Sustainability Journey and the Global Climate Crisis | Hakan Bulgurlu, CEO, Arçelik AS.
00:10:00
Jim Nesci on Blue Foundry Bank's Expansion and Competitive Edge | James D. Nesci, CEO, Blue Foundry Bank.
00:00:00
Anthropologist and psychiatrist / Anne E. Becker, MD, PhD, ScM Dean for Clinical and Academic Affairs, HMS
00:10:00
B2B software focused venture fund, program, and community with offices in San Francisco|Jonah Midanik,COO & General Partner,Forum Ventures (fka Accelprise)
00:00:00
Christopher J. Schaber, CEO, Soligenix Inc
00:10:00
we are focused on discovering developing and commercializing novel gene and cell therapies and vaccines|Jon Lieber, Chief Financial Officer,Histogenics Corp
00:10:00
Mastering Arbitrage Funds: Insights and Strategies for Smarter Investing | Bhavesh Jain - Co-Head, Factor Investing, Edelweiss Mutual Fund
00:10:00
SkyWater Technology's unique positioning reduces its exposure to semiconductor cyclicality, according to CEO Thomas Sonderman.
00:10:00
Appia Rare Earths and Uranium Corp: Exploring High-Grade Critical Minerals in Canada

© 2026 Nehu